Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genevation LTD
Stevenage, England, United Kingdomgenevation.co.uk ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Genevation LTD is developing and manufacturing personalized mRNA-based cancer vaccines. Their approach uses information about an individual’s tumor to create a tailored vaccine designed to kill or inhibit the growth of that person’s cancer cells. The company is currently at the preclinical stage and has established partnerships with leading academic and industry players such as University of Cambridge and Illumina.
- Therapeutic areas
- Oncology
- Modalities
- mRNA vaccines
- Industry
- Biotech
02
Partnerships
University of CambridgeIllumina
Beyond the preview
Go deeper on Genevation LTD.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genevation LTD.